453 related articles for article (PubMed ID: 29518183)
21. GATA-4-expressing mouse bone marrow mesenchymal stem cells improve cardiac function after myocardial infarction via secreted exosomes.
He JG; Li HR; Han JX; Li BB; Yan D; Li HY; Wang P; Luo Y
Sci Rep; 2018 Jun; 8(1):9047. PubMed ID: 29899566
[TBL] [Abstract][Full Text] [Related]
22. Exosomes From Human Cardiac Progenitor Cells for Therapeutic Applications: Development of a GMP-Grade Manufacturing Method.
Andriolo G; Provasi E; Lo Cicero V; Brambilla A; Soncin S; Torre T; Milano G; Biemmi V; Vassalli G; Turchetto L; Barile L; Radrizzani M
Front Physiol; 2018; 9():1169. PubMed ID: 30197601
[TBL] [Abstract][Full Text] [Related]
23. Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4.
Xiao J; Pan Y; Li XH; Yang XY; Feng YL; Tan HH; Jiang L; Feng J; Yu XY
Cell Death Dis; 2016 Jun; 7(6):e2277. PubMed ID: 27336721
[TBL] [Abstract][Full Text] [Related]
24. Apoptosis-Resistant Cardiac Progenitor Cells Modified With Apurinic/Apyrimidinic Endonuclease/Redox Factor 1 Gene Overexpression Regulate Cardiac Repair After Myocardial Infarction.
Aonuma T; Takehara N; Maruyama K; Kabara M; Matsuki M; Yamauchi A; Kawabe J; Hasebe N
Stem Cells Transl Med; 2016 Aug; 5(8):1067-78. PubMed ID: 27334489
[TBL] [Abstract][Full Text] [Related]
25. Platelet-derived growth factor-BB enhances MSC-mediated cardioprotection via suppression of miR-320 expression.
Xu B; Luo Y; Liu Y; Li BY; Wang Y
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H980-9. PubMed ID: 25724494
[TBL] [Abstract][Full Text] [Related]
26. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury.
Arslan F; Lai RC; Smeets MB; Akeroyd L; Choo A; Aguor EN; Timmers L; van Rijen HV; Doevendans PA; Pasterkamp G; Lim SK; de Kleijn DP
Stem Cell Res; 2013 May; 10(3):301-12. PubMed ID: 23399448
[TBL] [Abstract][Full Text] [Related]
27. Beneficial effects of exosomes secreted by cardiac-derived progenitor cells and other cell types in myocardial ischemia.
Barile L; Milano G; Vassalli G
Stem Cell Investig; 2017; 4():93. PubMed ID: 29270419
[TBL] [Abstract][Full Text] [Related]
28. IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway.
Lin M; Liu X; Zheng H; Huang X; Wu Y; Huang A; Zhu H; Hu Y; Mai W; Huang Y
Stem Cell Res Ther; 2020 Jan; 11(1):22. PubMed ID: 31918758
[TBL] [Abstract][Full Text] [Related]
29. Exploring Cutting-Edge Approaches to Potentiate Mesenchymal Stem Cell and Exosome Therapy for Myocardial Infarction.
Peng C; Yan J; Jiang Y; Wu L; Li M; Fan X
J Cardiovasc Transl Res; 2024 Apr; 17(2):356-375. PubMed ID: 37819538
[TBL] [Abstract][Full Text] [Related]
30. Plasma exosomes protect the myocardium from ischemia-reperfusion injury.
Vicencio JM; Yellon DM; Sivaraman V; Das D; Boi-Doku C; Arjun S; Zheng Y; Riquelme JA; Kearney J; Sharma V; Multhoff G; Hall AR; Davidson SM
J Am Coll Cardiol; 2015 Apr; 65(15):1525-36. PubMed ID: 25881934
[TBL] [Abstract][Full Text] [Related]
31. Pretreatment of Cardiac Stem Cells With Exosomes Derived From Mesenchymal Stem Cells Enhances Myocardial Repair.
Zhang Z; Yang J; Yan W; Li Y; Shen Z; Asahara T
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26811168
[TBL] [Abstract][Full Text] [Related]
32. Exosomes from Cardiomyocyte Progenitor Cells and Mesenchymal Stem Cells Stimulate Angiogenesis Via EMMPRIN.
Vrijsen KR; Maring JA; Chamuleau SA; Verhage V; Mol EA; Deddens JC; Metz CH; Lodder K; van Eeuwijk EC; van Dommelen SM; Doevendans PA; Smits AM; Goumans MJ; Sluijter JP
Adv Healthc Mater; 2016 Oct; 5(19):2555-2565. PubMed ID: 27570124
[TBL] [Abstract][Full Text] [Related]
33. Exosomes Derived from Akt-Modified Human Umbilical Cord Mesenchymal Stem Cells Improve Cardiac Regeneration and Promote Angiogenesis via Activating Platelet-Derived Growth Factor D.
Ma J; Zhao Y; Sun L; Sun X; Zhao X; Sun X; Qian H; Xu W; Zhu W
Stem Cells Transl Med; 2017 Jan; 6(1):51-59. PubMed ID: 28170176
[TBL] [Abstract][Full Text] [Related]
34. Lipopolysaccharides Improve Mesenchymal Stem Cell-Mediated Cardioprotection by MyD88 and stat3 Signaling in a Mouse Model of Cardiac Ischemia/Reperfusion Injury.
Chu X; Xu B; Gao H; Li BY; Liu Y; Reiter JL; Wang Y
Stem Cells Dev; 2019 May; 28(9):620-631. PubMed ID: 30808255
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-10 Deficiency Alters Endothelial Progenitor Cell-Derived Exosome Reparative Effect on Myocardial Repair via Integrin-Linked Kinase Enrichment.
Yue Y; Wang C; Benedict C; Huang G; Truongcao M; Roy R; Cimini M; Garikipati VNS; Cheng Z; Koch WJ; Kishore R
Circ Res; 2020 Jan; 126(3):315-329. PubMed ID: 31815595
[No Abstract] [Full Text] [Related]
36. Exosomes derived from adipose tissue, bone marrow, and umbilical cord blood for cardioprotection after myocardial infarction.
Xu H; Wang Z; Liu L; Zhang B; Li B
J Cell Biochem; 2020 Mar; 121(3):2089-2102. PubMed ID: 31736169
[TBL] [Abstract][Full Text] [Related]
37. Engineered bone marrow mesenchymal stem cell-derived exosomes loaded with miR302 through the cardiomyocyte specific peptide can reduce myocardial ischemia and reperfusion (I/R) injury.
Gu J; You J; Liang H; Zhan J; Gu X; Zhu Y
J Transl Med; 2024 Feb; 22(1):168. PubMed ID: 38368334
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction.
Zhu LP; Tian T; Wang JY; He JN; Chen T; Pan M; Xu L; Zhang HX; Qiu XT; Li CC; Wang KK; Shen H; Zhang GG; Bai YP
Theranostics; 2018; 8(22):6163-6177. PubMed ID: 30613290
[TBL] [Abstract][Full Text] [Related]
39. Engineered Exosomes With Ischemic Myocardium-Targeting Peptide for Targeted Therapy in Myocardial Infarction.
Wang X; Chen Y; Zhao Z; Meng Q; Yu Y; Sun J; Yang Z; Chen Y; Li J; Ma T; Liu H; Li Z; Yang J; Shen Z
J Am Heart Assoc; 2018 Aug; 7(15):e008737. PubMed ID: 30371236
[TBL] [Abstract][Full Text] [Related]
40. Strategic advantages of insulin-like growth factor-I expression for cardioprotection.
Chao W; Matsui T; Novikov MS; Tao J; Li L; Liu H; Ahn Y; Rosenzweig A
J Gene Med; 2003 Apr; 5(4):277-86. PubMed ID: 12692862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
